Table 1 Patient characteristics at baseline
Total n = 111 | Myocarditis (Group 1) (n = 20) | No myocarditis (Group 2) (n = 91) | p-value | |
|---|---|---|---|---|
Female | 42 (38) | 7 (35) | 35 (38) | 0.999 |
Ethnicity | 0.203 | |||
Caucasian | 36/100 (36) | 10/19 (53) | 26/81 (32) | |
Afro-American | 45/100 (45) | 5/19 (26) | 40/81 (49) | |
Asian | 8/100 (8) | 1/19 (5) | 7/81 (9) | |
Hispanic | 11/100 (11) | 3/19 (16) | 8/81 (10) | |
Age at symptom onset, years | 10.0 (7.0–13.8) | 10.7 (7.5–16.0) | 10.0 (7.0–13.0) | 0.370 |
Comorbiditya | 25/106 (24) | 6/19 (32) | 19/87 (22) | 0.380 |
COVID serology positive | 96/98 (98) | 18/18 (100) | 78/80 (98) | 0.999 |
COVID PCR and serology positive | 30/111 (27) | 4/20 (20) | 26/91 (29) | 0.611 |
Duration between symptom onset and hospital admission, days | 5 (4–6) | 4 (4–6) | 5 (4–6) | 0.200 |
Follow-up duration (days) | 55 (43–100) | 53 (39–81) | 58 (44–105) | 0.641 |